BioCentury
ARTICLE | Financial News

Raven raises $40 million

January 3, 2003 8:00 AM UTC

Cancer antibody developer Raven Biotechnologies (South San Francisco, Calif.) raised $40 million in a series C round led by Bear Stearns Health Innoventures. Other investors included Pequot Ventures; ...